31. Endovascular brachytherapy  by Pötter, R.
2. re-irradiation;
3. brachytherapy;
4. integration of radiotherapy with the other
methods ot palliative and symptomatic care.
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R. P6tter
32.
QUALlTY ASSURANCE FOR NEW
TECHNIQUES OF BRACHYTHERAPY
G. Marinello, B. Gres
Unitś de Radiophysique et Radioprotection,
H6pital HENRI MONDOR, 94010 CRETEIL
(France)
In addition to c1assical HDR, PDR or LDR
brachytherapy, new techniques such as
transperineal radioactive implantations of the
prostate via template guidance, or vascular
brachytherapy for the prevention of restenosis,
are becoming increasingly popular. At the same
time they are introduced in a department, a
quality assurance program must be
implemented both to minimize the risks of
treatment misadministrations and to prove
respect to legal Iiability.
The authors try to point out the necessary
equipments and the particularities ot Q.A.
programs which must cover all the steps of the
treatment. They consider successively prostate
and vascular brachytherapy, making for each ot
them, a quick review of the most current
techniques (including associated accessories
and imaging devices), showing the particularities
ot adapted computerized treatment planning
systems and the characteristics ot radioactive
sources usually used (photon sources tor
prostate such as 192 Ir tor temporary implants
and 1251 and 103 Pd tor permanent implants, 192 Ir
or beta sources for vessels). Particular detectors
and methods to be employed to pertorm quality
controls of equipments and sources, or in vivo
measurements, are also presented. Lastly the
guidelines and recommendations tor "good
practice and quality assurance" concerning
these particular techniques and published by
different international organizations, or which
are in the process of development, are
summarized. It will be noted that volume
detinitions, dose prescription and reporting,
dose planning, dosimetry, staffing and
responsabilities,etc, are or should be included in
a complete quality assurance program.
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33.
LAST RESULTS AND LESSONS OF
THE ESTRO EUROPEAN NETWORK
ON QUALlTY ASSURANCE IN
RADIOTHERAPY
I.H. Ferreira\ A.Dutreix\ A.Bridier2, D.Marre2,
J.Chavaudra2, H. Svensson3
1ESTRO-EQUAL Measuring Laboratory, Service
de Physique, Institut Gustave Roussy, 94805
Villejuit, France, 2Service de Physique, Institut
Gustave Roussy, 94805 Villejuit, France,
3Radiation Physics Department, University ot
Umea, 90185 Umea, Sweden.
State of the Art: The EQUAL Dosimetry audit
service, set-up by the ESTRO in 1998a, is well-
known through large numbers ot TL-dosimeters
sent to hospitals to be irradiated in clinically
relevant conditions, and read at the EQUAL
Measuring Laboratory, IGR, Villejuit.
Ali European countries have now applied to
participate (404 centres out of 880) for photon
and electron beams. In relation with the IAEA,
this service has been extended to 27 centres ot
7 countries trom Eastern and Central Europe,
and the Mediterranean Basin. 757 photon
beams and 277 electron beams have been
checked according to the "on the beam axis"
procedure.
Results and outcome:
Reference beam output results
demonstrating improvements with respect to
the former EC Network, and good reliability
of the procedure: mean ratios of measured
to stated dose of 0.997 (SD 1.8%) tor
photon beams, and 1.003 (SD 2.1 %) for
electron beams.
Useful service detecting 7% of the photon
beams presenting at least one check point
with a deviation > 5% (2% tor electron
beams, but 3 times more deviations
between 3 and 5%).
Re-checks and on-site visits in 8 centres
reveal inaccuracies in TPS algorithms or
input data and/or in local measurements
(wedge tactors, collimator aperture tactors,
PDD's, beams calibrations).
Conclusion: A number ot dosimetric
problems are still observed, even on the beam
axis. Improvements should be introduced and
checked before considering more sophisticated
treatment techniques.
a The present ESTRO-EQUAL Project (MORQA)
has been tunded by an EU contract.
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